Dawn Brown
About Dawn Brown
Dawn Brown is the Associate Director of WW HEOR Strategy & Operations at Bristol Myers Squibb, with extensive experience in project management and organizational engagement.
Title and Current Role
Dawn Brown is the Associate Director, WW HEOR Strategy & Operations at Bristol Myers Squibb. In this role, she plays a key part in setting the agenda for strategic and operational discussions within the organization. Her responsibilities also include organizing team leadership and extended leadership meetings to ensure that key decisions are executed across various stakeholders.
Career at Bristol Myers Squibb
Dawn Brown has held several roles at Bristol Myers Squibb, showcasing her extensive experience in the field. She served as WWHEOR Medical Operations_Oncology from 2018 to 2020, Protocol Manager from 2017 to 2018, and Global Study Manager from 2015 to 2017. In each of these roles, she effectively managed business processes, collaborated closely with Senior Management, and contributed to building organizational engagement.
Previous Roles at Novo Nordisk
Dawn Brown worked at Novo Nordisk for nearly a decade, beginning her tenure as an In-House CRA from 2007 to 2015 before advancing to the role of Senior inHouse CRA from 2014 to 2015. Her work here involved extensive project management, identifying risks, and working effectively with matrix teams.
Other Professional Experience
Before her time at Bristol Myers Squibb and Novo Nordisk, Dawn Brown held roles at i3 Research as Project Research Associate from 2006 to 2007, Radpharm Imaging Core Lab as Project Leader from 2003 to 2006, and Schering-Plough Research Institute as Clinical Information Specialist for 8 months in 2003. These roles contributed to her broad experience in clinical research and project management.
Education and Certifications
Dawn Brown holds a Bachelor of Science (BS) in Biology from New Jersey City University. She also completed a Certificate in Clinical Development and Regulatory Affairs from Mercer County Community College from 2011 to 2012. These academic achievements underpin her detailed knowledge and expertise in clinical development and project management.